What Is Merkel Cell Carcinoma and How Do Families Plan for End of Life?

The short answer: Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer with neuroendocrine features. When metastatic, it carries a poor prognosis despite recent advances in immunotherapy. Early palliative care integration and end-of-life planning are critical given its rapid progression.

Understanding Merkel Cell Carcinoma

MCC arises from Merkel cells in the skin and is strongly associated with Merkel cell polyomavirus (MCPyV) and UV exposure, particularly in elderly immunocompromised individuals. It is rare — approximately 3,000 cases annually in the U.S. — but has a high recurrence and metastasis rate.

Prognosis and Immunotherapy

Stage IV MCC has historically had poor prognosis, but PD-1/PD-L1 immune checkpoint inhibitors (avelumab, pembrolizumab) have improved outcomes significantly. Durable responses occur in 30–40% of treated patients, though most eventually progress.

When Disease Progresses Despite Immunotherapy

For patients who progress on immunotherapy, options are limited. Clinical trials and chemotherapy can be considered, but median survival after immunotherapy failure is months. Early integration of palliative care ensures comfort is prioritized alongside treatment.

End-of-Life Planning for MCC Families

Because MCC often progresses rapidly, families should begin advance care planning early. Legacy work, legal document preparation, and honest conversations about goals of care are essential. Death doulas can help facilitate these conversations and support families through uncertain timelines.

Frequently Asked Questions

What is the survival rate for metastatic Merkel cell carcinoma?

With immunotherapy, median overall survival for stage IV MCC is approximately 12–20 months, with durable long-term responses in a minority of patients.

Is Merkel cell carcinoma curable?

Early-stage MCC can be cured with surgery and radiation. Metastatic MCC is generally incurable but may achieve prolonged remission with immunotherapy.

How can a death doula help with rare skin cancer end-of-life planning?

Death doulas help families with MCC navigate compressed timelines, facilitate family communication, support legacy work, and provide emotional presence during a frightening rare diagnosis.

What immunotherapy is approved for Merkel cell carcinoma?

Avelumab (Bavencio) and pembrolizumab (Keytruda) are FDA-approved for advanced MCC. Both are PD-1/PD-L1 checkpoint inhibitors.

Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.